Hepatitis Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)
Conditions:   Vaccine Reaction;   Vaccine Adverse Reaction Interventions:   Biological: Hepatitis B vaccine lot 1;   Biological: Hepatitis B vaccine lot 2;   Biological: Hepatitis B vaccine lot 3;   Biological: Hepatitis B vaccine (registered) Sponsors:   PT Bio Farma;   RS Umum Pusat Sanglah, Denpasar Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2022 Category: Research Source Type: clinical trials

Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)
Conditions:   Diphtheria Vaccine Adverse Reaction;   Tetanus Vaccine Adverse Reaction;   Pertussis Vaccine Adverse Reaction;   Haemophilus Influenzae Type B Vaccine Adverse Reaction;   Hepatitis B Vaccine Adverse Reaction Interventions:   Biological: Recombinant Hepatitis B new Bulk vaccine;   Biological: DTP-HB-Hib with Recombinant Hepatitis B new Bulk vaccine;   Biological: Recombinant Hepatitis B vaccine (Registered BioFarma);   Biological: Pentabio Sponsors:   PT Bio Farma;   Hasan Sadikin General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2022 Category: Research Source Type: clinical trials

Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)
Conditions:   Vaccine Reaction;   Vaccine Adverse Reaction Interventions:   Biological: Hepatitis B vaccine lot 1;   Biological: Hepatitis B vaccine lot 2;   Biological: Hepatitis B vaccine lot 3;   Biological: Hepatitis B vaccine (registered) Sponsors:   PT Bio Farma;   RS Umum Pusat Sanglah, Denpasar Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2022 Category: Research Source Type: clinical trials

Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)
Conditions:   Diphtheria Vaccine Adverse Reaction;   Tetanus Vaccine Adverse Reaction;   Pertussis Vaccine Adverse Reaction;   Haemophilus Influenzae Type B Vaccine Adverse Reaction;   Hepatitis B Vaccine Adverse Reaction Interventions:   Biological: Recombinant Hepatitis B new Bulk vaccine;   Biological: DTP-HB-Hib with Recombinant Hepatitis B new Bulk vaccine;   Biological: Recombinant Hepatitis B vaccine (Registered BioFarma);   Biological: Pentabio Sponsors:   PT Bio Farma;   Hasan Sadikin General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2022 Category: Research Source Type: clinical trials

Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)
Conditions:   Vaccine Reaction;   Vaccine Adverse Reaction Interventions:   Biological: Hepatitis B vaccine lot 1;   Biological: Hepatitis B vaccine lot 2;   Biological: Hepatitis B vaccine lot 3;   Biological: Hepatitis B vaccine (registered) Sponsors:   PT Bio Farma;   RS Umum Pusat Sanglah, Denpasar Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2022 Category: Research Source Type: clinical trials

Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)
Conditions:   Diphtheria Vaccine Adverse Reaction;   Tetanus Vaccine Adverse Reaction;   Pertussis Vaccine Adverse Reaction;   Haemophilus Influenzae Type B Vaccine Adverse Reaction;   Hepatitis B Vaccine Adverse Reaction Interventions:   Biological: Recombinant Hepatitis B new Bulk vaccine;   Biological: DTP-HB-Hib with Recombinant Hepatitis B new Bulk vaccine;   Biological: Recombinant Hepatitis B vaccine (Registered BioFarma);   Biological: Pentabio Sponsors:   PT Bio Farma;   Hasan Sadikin General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2022 Category: Research Source Type: clinical trials

Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)
Conditions:   Vaccine Reaction;   Vaccine Adverse Reaction Interventions:   Biological: Hepatitis B vaccine lot 1;   Biological: Hepatitis B vaccine lot 2;   Biological: Hepatitis B vaccine lot 3;   Biological: Hepatitis B vaccine (registered) Sponsors:   PT Bio Farma;   RS Umum Pusat Sanglah, Denpasar Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2022 Category: Research Source Type: clinical trials

Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)
Conditions:   Diphtheria Vaccine Adverse Reaction;   Tetanus Vaccine Adverse Reaction;   Pertussis Vaccine Adverse Reaction;   Haemophilus Influenzae Type B Vaccine Adverse Reaction;   Hepatitis B Vaccine Adverse Reaction Interventions:   Biological: Recombinant Hepatitis B new Bulk vaccine;   Biological: DTP-HB-Hib with Recombinant Hepatitis B new Bulk vaccine;   Biological: Recombinant Hepatitis B vaccine (Registered BioFarma);   Biological: Pentabio Sponsors:   PT Bio Farma;   Hasan Sadikin General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2022 Category: Research Source Type: clinical trials

Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)
Conditions:   Vaccine Reaction;   Vaccine Adverse Reaction Interventions:   Biological: Hepatitis B vaccine lot 1;   Biological: Hepatitis B vaccine lot 2;   Biological: Hepatitis B vaccine lot 3;   Biological: Hepatitis B vaccine (registered) Sponsors:   PT Bio Farma;   RS Umum Pusat Sanglah, Denpasar Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2022 Category: Research Source Type: clinical trials

Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)
Conditions:   Diphtheria Vaccine Adverse Reaction;   Tetanus Vaccine Adverse Reaction;   Pertussis Vaccine Adverse Reaction;   Haemophilus Influenzae Type B Vaccine Adverse Reaction;   Hepatitis B Vaccine Adverse Reaction Interventions:   Biological: Recombinant Hepatitis B new Bulk vaccine;   Biological: DTP-HB-Hib with Recombinant Hepatitis B new Bulk vaccine;   Biological: Recombinant Hepatitis B vaccine (Registered BioFarma);   Biological: Pentabio Sponsors:   PT Bio Farma;   Hasan Sadikin General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2022 Category: Research Source Type: clinical trials